- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03618693
Impact of Perioperative Analgesia in Prostatectomy Patients on Early Quality of Recovery (SPITALIDO) (SPITALIDO)
The Impact of Perioperative Analgesia in Prostatectomy Patients on Early Quality of Recovery
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Prostatectomy (open or robotic assisted) is a major urological surgery, which is associated with relevant acute postoperative pain. Perioperative analgesic techniques aiming at optimizing postoperative analgesia have to be investigated. Optimal postoperative pain management is one of the key factors leading to enhanced recovery after surgery. Optimal analgesia should aim for optimized patient comfort, fast functional recovery with the fewest side effects thus encouraging the DREAMS concept (DRinking, EAting, Mobilizing and Sleeping).
The perioperative additional use of a spinal single shot analgesia, or a transversus abdominis plane block to general anaesthesia are validated options to enhance pain therapy compared to systemic analgesia alone. However, if the impact on pain scores has been described previously, the impact on the quality of recovery (QoR) is still unclear. Using the assessment of QoR allows for a much more objective and broader assessment of the quality of the postoperative treatment. Indeed, patient's perioperative experience cannot be only focused on pain scores but should involve items like physical independence, patient support, comfort, emotion. All these items are included in already validated QoR questionnaires like the QoR 15 or QoR 40.
The rationale behind this randomized, parallel group, single centre, interventional, active controlled trial is to assess with the QoR 15questionnaire within 24 hours after surgery the quality of recovery of prostatectomy patients treated with 3 different analgesia concepts.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
BE
-
Bern, BE, Switzerland, 3010
- Patrick Wuethrich, Department of Anaesthesiology and Pain Therapy, University Hospital Bern Inselspital Bern
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Informed Consent as documented by signature (Appendix Informed Consent Form)
- >18 years old
- eGFR >40ml/min
- Normal liver function
- Prostatectomy (open, robotic assisted)
Exclusion Criteria:
- Contraindications to the class of drugs under study, e.g. known hypersensitivity or allergy to class of drugs or the investigational product,
- Patients with regular use of antiemetics, laxatives, opioids or other types of analgesics
- Known or suspected non-compliance, drug or alcohol abuse,
- Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant,
- Participation in another study with investigational drug within the 30 days preceding and during the present study,
- Previous enrolment into the current study,
- Enrolment of the investigator, his/her family members, employees and other dependent persons,
- Severe psychiatric disorder
- Patients with chronic pain
- Preoperative regular use of non-steroidal anti-inflammatory drugs
- Refusal of regional analgesia (SSS or TAP block)
- Contraindication to regional analgesia (SSS or TAP block)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: spinal analgesia SSS
Patients will receive a spinal analgesia (group SSS) with a single shot of bupivacaine 0.5% combined with fentanyl intrathecally during induction of anaesthesia. The technique used is referred to daily practice. All patients included in the study will receive the same postoperative multimodal analgesia starting at the end of surgery with the following regimen: 30 mg ketorolac 3* per day for 48 hours intravenously and 1 gr 4* per day metamizol intravenously or per oral, depending of the return of bowel function as baseline analgesia during length of hospitalization. Additional rescue analgesia will be provided and consisted in boluses of 25 mcg fentanyl intravenously (first 24 hours) and thereafter 5-10 mg oxycodone tablets (per oral administration). Postoperative rehabilitation according to the investigators enhanced recovery program including early mobilization and drinking (clear drinks). |
Injection of a single shot of local anesthetic bupivacaine 0.5% combined with 20 mcg fentanyl intrathecally.
|
Experimental: TAP block
Patients will receive a TAP block with a single shot of ropivacaine 0.375% combined with clonidine bilaterally. The technique used is referred to daily practice. The blocks will be performed under ultrasound guidance. All patients included in the study will receive the same postoperative multimodal analgesia starting at the end of surgery with the following regimen: 30 mg ketorolac 3* per day for 48 hours intravenously and 1 gr 4* per day metamizol intravenously or per oral, depending of the return of bowel function as baseline analgesia during length of hospitalization. Additional rescue analgesia will be provided and consisted in boluses of 25 mcg fentanyl intravenously (first 24 hours) and thereafter 5-10 mg oxycodone tablets (per oral administration). Postoperative rehabilitation according to the investigators enhanced recovery program including early mobilization and drinking (clear drinks). |
TAP block with a single shot of 20ml ropivacaine 0.375% combined with 75 mcg clonidine bilaterally
|
Active Comparator: Standard
Standard care for prostatectomy in the investigators institution consists in the concomitant systemic administration of lidocaine to standard general anaesthesia. Lidocaine will administered initially during induction with a bolus of 1.5 mg per kgBW, followed by an infusion of 1.5 mg per kgBW per hour for 24 hours. All patients included in the study will receive the same postoperative multimodal analgesia starting at the end of surgery with the following regimen: 30 mg ketorolac 3* per day for 48 hours and 1 gr 4* per day metamizol intravenously or per oral, depending of the return of bowel function as baseline analgesia during length of hospitalization. Additional rescue analgesia will be provided and consisted in boluses of 25 mcg fentanyl intravenously (first 24 hours) and thereafter 5-10 mg oxycodone tablets. Postoperative rehabilitation according to the investigators enhanced recovery program including early mobilization and drinking (clear drinks). |
Concomitant systemic administration of lidocaine (as an adjuvant) to the standard general anaesthesia.
Lidocaine will administered initially during induction with a bolus of 1.5 mg per kgBW, followed by an infusion of 1.5 mg per kgBW per hour for 24 hours.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Quality of Recovery
Time Frame: From preoperative to postoperative day (POD) 1 i.e. within 24 hours after initiation of intervention
|
Changes in Quality of Recovery using the validated 15 items quality of recovery (QoR-15) score : QoR is a patient reported outcome short questionnaire that measure the quality of recovery after surgery and anaesthesia.
It incorporates 5 dimensions of health (patient support, comfort, emotions, physical independence, pain).
This is a shortened validated version of the QoR 40 including 15 items.
QoR-15, with a score range from 0 to 150, is easy to perform.
Recently a meta-analysis showed that QoR 15 fulfils requirements for outcome measurement instruments.
|
From preoperative to postoperative day (POD) 1 i.e. within 24 hours after initiation of intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Postoperative Nausea and Vomiting (PONV)
Time Frame: during the first 48 hours postoperatively
|
Groups will be assessed for postoperative nausea/vomiting by verbal descriptive scale at 6, 24 and 48 hours respectively. Verbal descriptive Scale 0 No nausea
|
during the first 48 hours postoperatively
|
Pain Score
Time Frame: within 6 hours postoperatively, on POD 1 and 2
|
Pain will be assessed with the use of pain scores (incisional pain, "deep" visceral pain and pain during coughing/mobilization) according to the validated numeric rating scale (NRS with a range of 0 (no pain) to 10 (maximal pain)).
|
within 6 hours postoperatively, on POD 1 and 2
|
Gastrointestinal Function
Time Frame: During length of stay, expected to be on average 5 to 7 days
|
Return of gastrointestinal function (first flatus, first defecation, tolerance to food) in days.
|
During length of stay, expected to be on average 5 to 7 days
|
Opioid Consumption
Time Frame: Within the first 48 hours postoperatively
|
Use/amount of opioids intraoperative and postoperatively (transformed in morphine equivalent per 24 hours)
|
Within the first 48 hours postoperatively
|
Collaborators and Investigators
Investigators
- Principal Investigator: Patrick Wüthrich, MD, University Hospital Berne
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- WUPD01-18
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pain
-
University Hospital Schleswig-HolsteinZealand University Hospital; European Regional Development Fund; Design School...CompletedPain, Acute | Pain, Chronic | Pain Measurement | Pain, CancerGermany
-
Flowonix MedicalApproved for marketingBack Pain | Leg Pain | Trunk Pain | Intractable Pain | Arm Pain
-
Dr. Negrin University HospitalCompletedPostoperative Pain, Acute | Postoperative Pain, ChronicSpain
-
George Washington UniversityRecruitingCervical Fusion | Pain, Back | Pain, Neck | Myofacial PainUnited States
-
Dow University of Health SciencesRecruitingLow Back Pain | Chronic Low-back Pain | Low Back Pain, Mechanical | Mechanical Low Back Pain | Pain, Chronic | Pain, Back | Lower Back Pain Chronic | CLBP - Chronic Low Back PainPakistan
-
Atatürk Chest Diseases and Chest Surgery Training...RecruitingPostoperative Pain | Postoperative Pain, Acute | Postoperative Pain, Chronic | VATSTurkey
-
Janssen Research & Development, LLCCompletedPain, Radiating | Pain, Burning | Pain, Crushing | Pain, Migratory | Pain, SplittingUnited States, France, Spain, Poland, Portugal
-
susanne beckerSNSFCompletedLow Back Pain | Pain, Acute | Pain, ChronicSwitzerland
-
Universitat Jaume ICompletedPain, Acute | Pain, Chronic | OncologySpain
-
Atatürk Chest Diseases and Chest Surgery Training...RecruitingPostoperative Pain | Thoracotomy | Postoperative Pain, Acute | Postoperative Pain, ChronicTurkey
Clinical Trials on Spinal anesthesia
-
Sao Jose do Rio Preto Medical SchoolUnknownHip Fractures | Knee Arthroplasty | Femur FractureBrazil
-
National Taiwan University HospitalCompleted
-
University Hospital, AntwerpTerminatedAnesthesia; Adverse Effect, Spinal and EpiduralBelgium
-
The Cleveland ClinicCompletedScoliosis | Patients Aged 55 or Older | BMI More Than 40 kg/m2United States
-
Bakirkoy Dr. Sadi Konuk Research and Training HospitalCompletedPregnancy Related | Regional Anesthesia Morbidity | Postdural Puncture HeadacheTurkey
-
Fraser HealthNot yet recruitingAnesthesia, Spinal | Neurosurgery | Ropivacaine | BupivacaineCanada
-
Cairo UniversityUnknownParamedian Spinal Anaesthesia | Real Time Ultrasound GuidingEgypt
-
Stanford UniversityWithdrawnHeadache | HypotensionUnited States
-
Ankara UniversityAhmet Onat Bermede; Süheyla Karadağ Erkoç; Volkan Baytaş; Bulut Varlı; Hanife Asuman...Completed
-
Diskapi Teaching and Research HospitalCompletedKnee Arthropathy | Hip Arthropathy | Anesthesia; Adverse Effect, Spinal and EpiduralTurkey